Navamedic Management
Management criteria checks 2/4
Navamedic's CEO is Kathrine E. Andreassen, appointed in Jan 2019, has a tenure of 5.33 years. total yearly compensation is NOK5.13M, comprised of 52.9% salary and 47.1% bonuses, including company stock and options. directly owns 3.82% of the company’s shares, worth NOK21.60M. The average tenure of the management team and the board of directors is 5.3 years and 2.4 years respectively.
Key information
Kathrine E. Andreassen
Chief executive officer
kr5.1m
Total compensation
| CEO salary percentage | 52.9% |
| CEO tenure | 5.3yrs |
| CEO ownership | 3.8% |
| Management average tenure | 5.3yrs |
| Board average tenure | 2.4yrs |
Recent management updates
Recent updates
Is Navamedic (OB:NAVA) Using Too Much Debt?
Sep 19
Here's Why Navamedic (OB:NAVA) Can Manage Its Debt Responsibly
Feb 18Shareholders Can Be Confident That Navamedic's (OB:NAVA) Earnings Are High Quality
Nov 09Is Navamedic (OB:NAVA) A Risky Investment?
Nov 02Here's Why Navamedic (OB:NAVA) Has A Meaningful Debt Burden
Feb 22We Think Navamedic (OB:NAVA) Can Stay On Top Of Its Debt
Sep 04Is Navamedic (OB:NAVA) Using Too Much Debt?
Apr 12If You Had Bought Navamedic (OB:NAVA) Stock Three Years Ago, You Could Pocket A 166% Gain Today
Feb 18
Is Navamedic (OB:NAVA) Using Debt Sensibly?
Dec 07CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | kr4m |
| Sep 30 2023 | n/a | n/a | kr24m |
| Jun 30 2023 | n/a | n/a | kr20m |
| Mar 31 2023 | n/a | n/a | kr43m |
| Dec 31 2022 | kr5m | kr3m | kr29m |
| Sep 30 2022 | n/a | n/a | kr12m |
| Jun 30 2022 | n/a | n/a | kr8m |
| Mar 31 2022 | n/a | n/a | kr4m |
| Dec 31 2021 | kr5m | kr2m | kr618k |
| Sep 30 2021 | n/a | n/a | -kr7m |
| Jun 30 2021 | n/a | n/a | -kr6m |
| Mar 31 2021 | n/a | n/a | -kr8m |
| Dec 31 2020 | kr4m | kr2m | -kr16m |
| Sep 30 2020 | n/a | n/a | -kr22m |
| Jun 30 2020 | n/a | n/a | -kr24m |
| Mar 31 2020 | n/a | n/a | -kr26m |
| Dec 31 2019 | kr3m | kr2m | -kr16m |
Compensation vs Market: Kathrine E.'s total compensation ($USD462.00K) is above average for companies of similar size in the Norwegian market ($USD312.48K).
Compensation vs Earnings: Kathrine E.'s compensation has been consistent with company performance over the past year.
CEO
Kathrine E. Andreassen (57 yo)
5.3yrs
Tenure
kr5,128,000
Compensation
Ms. Kathrine E. Gamborg Andreassen serves as Director at Observe Medical Asa since June 13, 2019. Ms. Andreassen has been Chief Executive Officer of Navamedic ASA since January 1, 2019. She is Chairman of...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Executive Officer | 5.3yrs | kr5.13m | 3.82% NOK 21.6m | |
| Chief Financial Officer | 4.4yrs | kr3.29m | 1.5% NOK 8.5m | |
| C.O.O. | no data | no data | no data | |
| Chief Scientific Officer | 5.3yrs | no data | 3.02% NOK 17.1m | |
| Marketing and Sales Director | no data | no data | no data | |
| Chief Business Development Officer | no data | no data | no data |
5.3yrs
Average Tenure
Experienced Management: NAVA's management team is seasoned and experienced (5.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Chairman | no data | kr415.00k | no data | |
| Independent Director | no data | kr240.00k | no data | |
| Independent Director | 7.3yrs | kr200.00k | no data | |
| Director | less than a year | no data | no data | |
| Independent Director | 2.9yrs | kr200.00k | no data | |
| Independent Director | 1.9yrs | no data | no data |
2.4yrs
Average Tenure
62yo
Average Age
Experienced Board: NAVA's board of directors are not considered experienced ( 2.4 years average tenure), which suggests a new board.